Epigenetic reprogramming modulates malignant properties of human liver cancer.
about
The Therapeutic Targets of miRNA in Hepatic Cancer Stem CellsTurning hepatic cancer stem cells inside out--a deeper understanding through multiple perspectives.Stem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancerDNA Methyltransferases Modulate Hepatogenic Lineage Plasticity of Mesenchymal Stromal Cells.Lgr5 Methylation in Cancer Stem Cell Differentiation and Prognosis-Prediction in Colorectal CancerLow-dose irradiation promotes Rad51 expression by down-regulating miR-193b-3p in hepatocytes.New insights on the role of epigenetic alterations in hepatocellular carcinoma.Regulation of HK2 expression through alterations in CpG methylation of the HK2 promoter during progression of hepatocellular carcinoma.Silencing DNA methyltransferase 1 (DNMT1) inhibits proliferation, metastasis and invasion in ESCC by suppressing methylation of RASSF1A and DAPK.Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies.Cancer stem cells in hepatocellular carcinoma: Therapeutic implications based on stem cell biology.The evolving concept of liver cancer stem cells.Molecular Pathogenesis of Hepatocellular Carcinoma.Transmembrane voltage potential of somatic cells controls oncogene-mediated tumorigenesis at long-range.Dysregulation of Iron Metabolism in Cholangiocarcinoma Stem-like Cells.Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages.Recent Advances in Understanding Cholangiocarcinoma.Epigenetic Reprogramming of Human Hepatoma Cells: A Low-Cost Option for Drug Metabolism Assessment.The Recent Advances on Liver Cancer Stem Cells: Biomarkers, Separation, and Therapy.Circulating miR-148a associates with sensitivity to adiponectin levels in human metabolic surgery for weight loss
P2860
Q26749450-02554826-770B-44D3-92E8-0330F90F1204Q27692697-7F1D4A29-242E-44E8-B4CA-EB3B288852A6Q28079205-875B12FA-0BD2-4DFF-A2DE-7CE0F29EC236Q33906459-5E5D1984-C179-403D-9AA5-C453CEFAAEDFQ35849680-8C63552D-5025-4130-B948-F198331A3E96Q36937402-2A7715FB-104D-410D-A640-29D83A4A2662Q37031728-08EEA13B-C4C1-4EBB-835C-CF5B4B50A97CQ37520359-EAB70751-6F28-4561-B260-A027552DCC44Q37536803-7382E0C9-13C6-40AB-A9F8-E850C411B3ACQ38472322-1B8AD743-4AF4-4DDE-915E-414228BD9A12Q38540375-1AF256E0-95CA-48B2-A0D6-DC800778C5B1Q39109959-658A5C46-69D3-4452-BB6A-94A67A9F4241Q41544729-076064BB-7C5B-4A39-B5CB-8D6B6D3F40E9Q42739122-36829EF5-45CD-4A2D-B4CC-F683D117B70AQ47097927-693D4F96-457D-43FF-9E08-05AFF9CB9D69Q47141807-ABA69336-7260-4DE7-A1E9-0818E44E9108Q47165549-22917E1C-C13F-48DF-995F-3D5B9B7EA257Q52718069-D7323050-14AF-4F42-ACC7-622027A80482Q53106095-48AC6968-3ACB-45EB-B1E1-286C07478A92Q56523935-B38AFB22-F7F1-4D49-B99E-DD6AC549768A
P2860
Epigenetic reprogramming modulates malignant properties of human liver cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Epigenetic reprogramming modulates malignant properties of human liver cancer.
@ast
Epigenetic reprogramming modulates malignant properties of human liver cancer.
@en
type
label
Epigenetic reprogramming modulates malignant properties of human liver cancer.
@ast
Epigenetic reprogramming modulates malignant properties of human liver cancer.
@en
prefLabel
Epigenetic reprogramming modulates malignant properties of human liver cancer.
@ast
Epigenetic reprogramming modulates malignant properties of human liver cancer.
@en
P2093
P2860
P50
P356
P1433
P1476
Epigenetic reprogramming modulates malignant properties of human liver cancer
@en
P2093
Agnes Holczbauer
Daekwan Seo
Marian Durkin
Matthew C Gillen
Snorri S Thorgeirsson
Valentina M Factor
P2860
P304
P356
10.1002/HEP.27026
P407
P577
2014-05-01T00:00:00Z